Response to Comment on Meek et al. Reappearance of C-Peptide During the Third Trimester in Type 1 Diabetes Pregnancy: Pancreatic Regeneration or Fetal Hyperinsulinism? Diabetes Care 2021;44:1826-1834.,Diabetes Care

当前位置： X-MOL 学术 › Diabetes Care › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Response to Comment on Meek et al. Reappearance of C-Peptide During the Third Trimester in Type 1 Diabetes Pregnancy: Pancreatic Regeneration or Fetal Hyperinsulinism? Diabetes Care 2021;44:1826-1834.
Diabetes Care ( IF 16.2 ) Pub Date : 2022-02-01 , DOI: 10.2337/dci21-0054
Claire L Meek _{1,

2,

3} , Richard A Oram ₄ , Timothy J McDonald _{4,

5} , Denice S Feig _{6,

7} , Andrew T Hattersley ₄ , Helen R Murphy _{2,

8,

9}

Affiliation

The Wellcome Trust-MRC Institute of Metabolic Science, Metabolic Research Laboratories, University of Cambridge, Addenbrooke's Hospital, Cambridge, U.K.
Wolfson Diabetes and Endocrinology Clinic, Cambridge University Hospitals, Addenbrooke's Hospital, Cambridge, U.K.
Department of Clinical Biochemistry, Cambridge University Hospitals, Addenbrooke's Hospital, Cambridge, U.K.
Department of Diabetes Research, University of Exeter, Royal Devon and Exeter Hospital, Exeter, U.K.
Academic Department of Blood Sciences, Royal Devon and Exeter NHS Foundation Trust, Exeter, U.K.
Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Department of Medicine, University of Toronto, Toronto, Canada.
Lunenfeld-Tanenbaum Research Institute, Toronto, Canada.
Department of Women and Children's Health, King's College London, St. Thomas' Hospital, London, U.K.
Norwich Medical School, Faculty of Medicine and Health Sciences, University of East Anglia, Norwich, U.K.